BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10872614)

  • 1. Antioxidative effects of Choi-oki-to and its ability to inhibit the progression of atheroma in KHC rabbits.
    Iizuka A; Iijima OT; Kondo K; Matsumoto A; Itakura H; Yoshie F; Komatsu Y; Takeda H; Matsumiya T
    J Atheroscler Thromb; 2000; 6(2):49-54. PubMed ID: 10872614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of Dai-saiko-to (Da-Chai-Hu-Tang) on the progression of atherosclerotic lesions in Kurosawa and Kusanagi-hypercholesterolemic rabbits.
    Iizuka A; Iijima OT; Yoshie F; Makino B; Amagaya S; Komatsu Y; Kondo K; Matsumoto A; Itakura H
    J Ethnopharmacol; 1998 Dec; 63(3):209-18. PubMed ID: 10030725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of San'o-shashin-to on the antioxidative mechanism in spontaneous familial hypercholesterolaemic rabbits.
    Iijima OT; Takeda H; Matsumiya T
    Pharmacol Res; 2000 Feb; 41(2):137-41. PubMed ID: 10623481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibitory effects of Silso-San-Gami on atherosclerosis in KHC rabbits.
    Park WH; Shin SS; Lee YC; Kim CH
    Thromb Res; 2004; 113(3-4):235-41. PubMed ID: 15140588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antioxidative properties of the kampo drugs TJ-9, TJ-15, TJ-23, TJ-96 and TJ-114].
    Ondrias K; Biskupic S; Hromadová M; Benes L
    Cesk Farm; 1992 Oct; 41(7-8):253-7. PubMed ID: 1490284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of traditional herbal medicine, Hwaotang, on atherosclerosis using the spontaneous familial hypercholesterolemia model, Kurosawa and Kusanagi-hypercholesterolemic rabbits and the venous thrombosis rats.
    Park WH; Hong MY; Chung KH; Kim HM; Lee YC; Kim CH
    Phytother Res; 2005 Oct; 19(10):846-53. PubMed ID: 16261513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvianolic acid B inhibits low-density lipoprotein oxidation and neointimal hyperplasia in endothelium-denuded hypercholesterolaemic rabbits.
    Yang TL; Lin FY; Chen YH; Chiu JJ; Shiao MS; Tsai CS; Lin SJ; Chen YL
    J Sci Food Agric; 2011 Jan; 91(1):134-41. PubMed ID: 20824680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive effects of cacao liquor polyphenols (CLP) on LDL oxidation and the development of atherosclerosis in Kurosawa and Kusanagi-hypercholesterolemic rabbits.
    Kurosawa T; Itoh F; Nozaki A; Nakano Y; Katsuda S; Osakabe N; Tsubone H; Kondo K; Itakura H
    Atherosclerosis; 2005 Apr; 179(2):237-46. PubMed ID: 15777537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of stable free radicals from kampo medicines TJ-9, TJ-15, TJ-23, TJ-96, TJ-114 and their antioxidant effect on low density lipoproteins.
    Ondrias K; Stasko A; Gergel D; Hromadová M; Benes L
    Free Radic Res Commun; 1992; 16(4):227-37. PubMed ID: 1505783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of Saiko-ka-ryukotsu-borei-to (Chai-Hu-Jia-Long-Gu-Mu-Li-Tang) against atherosclerosis in Kurosawa and Kusanagi-hypercholesterolemic (KHC) rabbits.
    Yoshie F; Iizuka A; Kubo M; Komatsu Y; Matsumoto A; Itakura H; Takeda H; Matsumiya T; Kondo K
    Pharmacol Res; 2001 May; 43(5):481-8. PubMed ID: 11394941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidative potentiality of a Kampo formulation measured by an ex vivo study.
    Ogawa H; Xu FH; Uebaba K; Origasa H; Kondoh K; Mikage M
    J Altern Complement Med; 2009 Mar; 15(3):267-74. PubMed ID: 19292654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidizability of low density lipoprotein and total antioxidative capacity of plasma are differently altered during induction and regression of hypercholesterolemia in rabbits.
    Schneider W; Dalferth P; Kelber O; Friedemann G; Haasis R; Heinle H
    Atherosclerosis; 1999 May; 144(1):69-72. PubMed ID: 10381279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
    Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
    Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keishi-bukuryo-gan prevents the progression of atherosclerosis in cholesterol-fed rabbit.
    Sekiya N; Tanaka N; Itoh T; Shimada Y; Goto H; Terasawa K
    Phytother Res; 1999 May; 13(3):192-6. PubMed ID: 10353155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidative effect of schisanhenol on human low density lipoprotein and its quantum chemical calculation.
    Yu LH; Liu GT; Sun YM; Zhang HY
    Acta Pharmacol Sin; 2004 Aug; 25(8):1038-44. PubMed ID: 15301737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alpha-tocopherol and astaxanthin on LDL oxidation and atherosclerosis in WHHL rabbits.
    Jacobsson LS; Yuan XM; Ziedén B; Olsson AG
    Atherosclerosis; 2004 Apr; 173(2):231-7. PubMed ID: 15064096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of atherosclerosis using an antioxidant].
    Ishii K; Kita T
    Nihon Ronen Igakkai Zasshi; 1990 Mar; 27(2):177-81. PubMed ID: 2384991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron and atherosclerosis: inhibition by the iron chelator deferiprone (L1).
    Matthews AJ; Vercellotti GM; Menchaca HJ; Bloch PH; Michalek VN; Marker PH; Murar J; Buchwald H
    J Surg Res; 1997 Nov; 73(1):35-40. PubMed ID: 9441790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S 12340: a potent inhibitor of the oxidative modification of low-density lipoprotein in vitro and ex vivo in WHHL rabbits.
    Breugnot C; Privat S; Guillonneau C; Regnier G; Bouzom F; Vilaine JP; Lenaers A
    J Pharmacol Exp Ther; 1994 May; 269(2):515-20. PubMed ID: 8182520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Dai-saiko-to (Da-Chai-Hu-Tang) on plasma lipids and atherosclerotic lesions in female heterozygous heritable Kurosawa and Kusanagi-hypercholesterolemic (KHC) rabbits.
    Yoshie F; Iizuka A; Komatsu Y; Matsumoto A; Itakura H; Kondo K
    Pharmacol Res; 2004 Sep; 50(3):223-30. PubMed ID: 15225663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.